A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells

Breast Cancer Research and Treatment

Volumn 121, Issue 1, 2010, Pages 233-240

  Yao, Yuan ^a   Zhou, Qun ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; ER ; Estrogen; Shikonin

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; SHIKONIN;

ARTICLE; BREAST EPITHELIUM; CANCER HORMONE THERAPY; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG STRUCTURE; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; NAPHTHOQUINONES; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 77951297556     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0547-2     Document Type: Article

References (27)

1. Jiangsu Xin Yi Xue Yuan (1986) Dictionary of Chinese Materia Medica. Shanghai Press of Science and Technology, Shanghai
2. Bown D (1995) Encyclopaedia of herbs and their uses. Dorling Kindersley, London
3. H Lee JY Lin 1995 (1988) Antimutagenic activity of extracts from anticancer drugs in Chinese medicine Mutat Res 204 229 234
4. GL Wang CB Chen JM Gao H Ni TS Wang L Chen 2005 Investigation on the molecular mechanisms of anti-hepatocarcinoma herbs of traditional Chinese medicine by cell cycle microarray Zhongguo Zhong Yao Za Zhi 30 50 54 1:CAS:528:DC%2BD28Xlt1Kjsbo%3D 15714802
5. W Wang PP Li 2003 The effects of herb lithospermum extract on MCF-7 cell and estrogen and progestogen levels in mice Zhongguo Zhong Yao Za Zhi 28 1062 1067 15615418
6. XP Guo XY Zhang SD Zhang 1991 Clinical trial on the effects of Shikonin mixture on later stage lung cancer Zhong Xi Yi Jie He Za Zhi 11 598 599 1:STN:280:DyaK383hslWnsA%3D%3D 1806305
7. X Chen L Yang JJ Oppenheim MZ Howard 2002 Cellular pharmacology studies of Shikonin derivatives Phytother Res 16 199 209 10.1002/ptr.1100 1:CAS:528:DC%2BD38Xks1Wrt7o%3D 12164262 (Pubitemid 34534943)
8. X Chen L Yang N Zhang JA Turpin RW Buckheit C Osterling JJ Oppenheim OM Howard 2003 Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1 Antimicrob Agents Chemother 47 2810 2816 10.1128/AAC.47.9.2810-2816.2003 1:CAS:528:DC%2BD3sXntFegsLw%3D 12936978 (Pubitemid 37040252)
9. Y Yoon YO Kim NY Lim WK Jeon HJ Sung 1999 Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line Planta Med 65 532 535 10.1055/s-1999-14010 1:CAS:528:DyaK1MXlsFSnsbY%3D 10483373 (Pubitemid 29399955)
10. F Singh D Gao MG Lebwohl H Wei 2003 Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells Cancer Lett 200 115 121 10.1016/S0304-3835(03)00239-8 1:CAS:528:DC%2BD3sXotVylsrc%3D 14568164 (Pubitemid 38366091)
11. PC Hsu YT Huang ML Tsai YJ Wang JK Lin MH Pan 2004 Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells J Agric Food Chem 52 6330 6337 10.1021/jf0495993 1:CAS:528:DC%2BD2cXntlOjtLw%3D 15453709
12. Z Wu L Wu L Li S Tashiro S Onodera T Ikejima 2004 p53-mediated cell cycle arrest and apoptosis induced by Shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells J Pharmacol Sci 94 166 176 10.1254/jphs.94.166 1:CAS:528:DC%2BD2cXhvVCgtrY%3D 14978355 (Pubitemid 38405131)
13. W Han L Li S Qiu Q Lu Q Pan Y Gu J Luo X Hu 2007 Shikonin circumvents cancer drug resistance by induction of a necroptotic death Mol Cancer Ther 6 1641 1649 10.1158/1535-7163.MCT-06-0511 1:CAS:528:DC%2BD2sXotFaltbo%3D 17513612 (Pubitemid 46954031)
14. T Hisa Y Kimura K Takada F Suzuki M Takigawa 1998 Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro Anticancer Res 18 783 790 1:STN:280:DyaK1c3nsl2mtg%3D%3D 9615720
15. N Yoshimi A Wang Y Morishita T Tanaka S Sugie K Kawai J Yamahara H Mori 1992 Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats Jpn J Cancer Res 83 1273 1278 1:CAS:528:DyaK3sXhtFKgt7w%3D 1483942
16. GJ Kapadia V Balasubramanian H Tokuda T Konoshima M Takasaki J Koyama K Tagahaya H Nishino 1997 Anti-tumor promoting effects of naphthoquinone derivatives on short term Epstein-Barr early antigen activation assay and in mouse skin carcinogenesis Cancer Lett 113 47 53 10.1016/S0304-3835(96)04582-X 1:CAS:528:DyaK2sXht1Kht7k%3D 9065800 (Pubitemid 27113227)
17. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 270 282 10.1056/NEJMra050776 1:CAS:528:DC%2BD28Xls1KjtQ%3D%3D 16421368 (Pubitemid 43113032)
18. M Ruff M Gangloff JM Wurtz D Moras 2000 Estrogen receptor transcription and transactivation: structure-function relationship in DNA- and ligand-binding domains of estrogen receptors Breast Cancer Res 2 353 359 10.1186/bcr80 1:CAS:528:DC%2BD3cXmtFWht74%3D 11250728 (Pubitemid 32223618)
19. VC Jordan 2002 The secrets of selective estrogen receptor modulation: cell-specific coregulation Cancer Cell 1 215 217 10.1016/S1535-6108(02)00050-8 1:CAS:528:DC%2BD38XjsFGltro%3D 12086856 (Pubitemid 41039144)
20. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins M Daly S Wieand E Tan-Chiu L Ford N Wolmark 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371 1388 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D 9747868
21. AT Ferguson RG Lapidus SB Baylin NE Davidson 1995 Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Res 55 2279 2283 1:CAS:528:DyaK2MXlvFeru7g%3D 7538900
22. Q Zhou P Atadja NE Davidson 2007 Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation Cancer Biol Ther 6 64 69 1:CAS:528:DC%2BD2sXhtVeqsb7P 17172825
23. Y Shang M Brown 2002 Molecular determinants for the tissue specificity of SERMs Science 295 2465 2468 10.1126/science.1068537 1:CAS:528: DC%2BD38XisFSksb4%3D 11923541 (Pubitemid 34270263)
24. M Chen J Ni HC Chang CY Lin M Muyan S Yeh 2009 CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells Carcinogenesis 30 841 850 10.1093/carcin/bgn288 1:CAS:528:DC%2BD1MXlsVChuro%3D 19126643
25. Zhang Y, Qian RQ, Li PP. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells. Cancer Lett 2009 (Epub ahead of print)
26. H Yang P Zhou H Huang D Chen N Ma QC Cui S Shen W Dong X Zhang W Lian X Wang QP Dou J Liu 2009 Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo Int J Cancer 124 2450 2459 10.1002/ijc.24195 1:CAS:528:DC%2BD1MXltFaqt7g%3D 19165859
27. F Yang Y Chen W Duan C Zhang H Zhu J Ding 2006 SH-7, a new synthesized Shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor Int J Cancer 119 1184 1193 10.1002/ijc.21943 1:CAS:528: DC%2BD28Xns1Cmsbk%3D 16570288 (Pubitemid 44116928)